The Safety Signal: Building a Just Culture in Allergy and Immunology

Join us as Monica Kraft, MD, FAAAAI, provides an evidence-based framework for managing allergic conditions during pregnancy, focusing on the safety of commonly used medications, from inhaled corticosteroids and antihistamines to biologics. We address the risks of undertreated asthma and explore the latest recommendations for penicillin allergy delabeling to optimize maternal-fetal outcomes. The discussion offers practical strategies for collaborating with OB-GYN colleagues to ensure safe, effective treatment throughout every trimester.View the Work Group Report: Penicillin Allergy Delabeling Can and Should Be Performed in Pregnant Patients: A Work Group Report of the AAAAI Women’s Health in Allergy and Immunology and Adverse Reaction to Drugs, Biologics and Vaccines Committees

In this episode, Christine Cho, MD, FAAAAI, discusses analyzing medical errors within the allergy clinic, from incorrect immunotherapy dosing to the systemic risks of penicillin mislabeling. Dr. Cho explains how shifting from a culture of blame to a "just culture" allows practices to transform "near misses" into learning opportunities that create more robust, reliable systems.

In honor of Food Allergy Awareness Week, we’re stepping out of the clinic and into the heat of the kitchen. Chef Ming Tsai shares an insider’s look at restaurant safety protocols, food allergy legislation and practical strategies physicians need to help patients with food allergies navigate the world with confidence.Find out more about food allergies. 

In this episode, we discuss the remarkable evolution of allergy and immunology through the lens of a career spanning six decades. Past AAAAI President Phil Lieberman, MD, FAAAAI, explores the pivotal scientific breakthroughs in the field starting with the discovery of IgE as he started in practice and taking us through target therapy has changed the lives of his patients. Dr. Lieberman offers us both historical perspective and guidance for physicians just starting in the field. Find out more about Dr. Lieberman. 

Climate change is reshaping the landscape of allergy and immunology in ways that directly affect human health. In this episode, Jeffrey G. Demain, MD, FAAAAI, discusses how rising temperatures, shifting weather patterns and increased carbon dioxide levels are intensifying allergic diseases and altering immune responses worldwide.

AAAAI President Carla Davis, MD, FAAAAI, discusses her journey in allergy / immunology including key mentors and the initiatives in education, research and advocacy that she will be advancing over the next year. Learn how you can access education tailored to your interests through AAAAI Ignite and advocate for your patients through AAAAI Advocate.AAAAI Advocate

Alpha-gal syndrome has transformed our understanding of food allergy, linking tick bites to delayed anaphylaxis to mammalian meats. In this episode, we explore the epidemiology, immunologic mechanisms, diagnosis and management of alpha-gal syndrome with expert Scott Commins, MD, FAAAAI. Join us for practical clinical pearls and emerging insights into this unique disease.Continuing Medical Education credit is available with this episode. Visit here to complete the assessment and claim credit. .75 AMA PRA Category 1 Credit(s)™.Find out more about alpha-gal.

GLP-1 agonists have been blockbuster medications in diabetes and obesity but they may also have a surprising role in the treatment of asthma. Join the conversation as Katherine Cahill, MD, FAAAAI, discusses how GLP-1 agonists may improve asthma control and reduce airway inflammation.Find out more about asthma. 

Vaccines are a cornerstone of public health, training the immune system to prevent infectious diseases, especially in our most vulnerable patients. In this episode, John Kelso, MD, FAAAAI, reviews recent vaccine developments, including the importance of measles vaccination amid ongoing outbreaks, updates to vaccination schedules, considerations when using vaccines with biologics and evaluation of vaccine allergy. Join us for a practical review of key vaccine updates to help you protect your patients. Find out more about the importance of vaccinations across age groups. 

Improving access to penicillin allergy evaluation for millions of older patients would lead to better antibiotic treatment, decreased surgical site infections and fewer cases of C. diff. The Penicillin Allergy Verification and Evaluation Act has the potential to do just this. Priya Bansal, MD, FAAAAI, and Allison Ramsey, MD, FAAAAI, share their valuable insight into the Act and how we can make advocacy a part of our practice. Find out more about the Penicillin Allergy Verification and Evaluation Act